Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor (TCR) specific for MHC-presented ESAT-6 and CFP-10 peptides is a pivotal mediator of the cellular immune response against Mycobacterium tuberculosis (Mtb). ESAT-6 (Early Secretory Antigenic Target 6 kDa) and CFP-10 (Culture Filtrate Protein 10 kDa) are highly immunogenic proteins secreted by Mtb via the ESX-1 secretion system and are notably absent in the Mycobacterium bovis BCG vaccine strain (Brodin et al., 2004, Trends in Microbiology). These antigens are processed by antigen-presenting cells and displayed on Major Histocompatibility Complex (MHC) molecules, where they are recognized by specific TCRs on CD4+ and CD8+ T-lymphocytes (Andersen, 2001, Trends in Immunology). This interaction triggers the release of protective cytokines such as interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha), which activate macrophages to contain or eliminate the intracellular pathogen (Kaufmann, 2013, Seminars in Immunology). Consequently, this TCR-antigen complex is a primary focus for the development of next-generation tuberculosis vaccines, such as H56:IC31, and serves as the biological basis for highly specific diagnostic Interferon-Gamma Release Assays (IGRAs) (Pai et al., 2014, Clinical Microbiology Reviews).
Activation of antigen-specific T-cells to induce a protective Th1 immune response and cytokine production (IFN-gamma, TNF-alpha) against Mycobacterium tuberculosis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor specific for MHC-presented ESAT-6 and CFP-10 peptides (TCR (ESAT-6/CFP-10)).